Amicus acquires rare disease gene therapy programs; Data shows black patients are underrepresented in clinical trials; Takeda acquires Molecular Templates.
Five things for pharma marketers to know: Thursday, September 13, 2018
Nostrum CEO blames FDA for 400% price hike; Boehringer Ingelheim acquires biotech ViraTherapeutics; Scientists make breakthrough discovery with BRCA1 gene.
Five things for pharma marketers to know: Friday, September 7, 2018